We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genetic Cause of Warburg Micro Syndrome Identified

By LabMedica International staff writers
Posted on 25 Nov 2013
A gene responsible for Warburg Micro syndrome, a rare genetic disease characterized by eye, brain, and endocrine abnormalities, has been identified by mutation screening.

Patients with Warburg Micro syndrome are severely challenged physically and mentally, unable to learn how to walk or speak, and become blind and paralyzed from an early age. More...


A collaborative team of scientists led by those at the Medical College of Wisconsin (Milwaukee, WI, USA) and the University of Edinburgh (UK) studied a cohort consisting of 77 individuals with a spectrum of Warburg micro syndrome (WARBM) disorders including 59 typical WARBM cases, five with the milder Martsolf syndrome, and 13 atypical cases. Some complementary studies were conducted in a murine model.

Mutation screening of the complete coding region of TBC1 Domain Family, Member 20 (TBC1D20), and three members of the RAS Oncogene Family RAB1A, RAB1B, and RAB2A was performed by direct sequence analysis in both directions by using genomic DNA extracted from venous blood. Real-time polymerase chain reaction (qPCR) analysis of genomic DNA from one individual was carried out on a LightCycler 480 (Roche Applied Science; Indianapolis, IN, USA) with primers designed to amplify coding regions of TBC1D20 as well as the 5′ and 3′ genes RanBP-Type and C3HC4-Type Zinc Finger Containing 1(RBCK1).

Clinical evaluation of individuals carrying pathogenic TBC1D20 mutations was sufficient to conclude that they cause a disease phenotype indistinguishable to that caused by mutations in genes encoding for Rab3 GTPase-activating protein catalytic subunit, RAB3GAP1, RAB3GAP2, or RAB18. The four genes do not comprise the full causative picture for Warburg Micro syndrome; in about half of the cases, the causing mutation was in none of those genes, which means there are additional novel genes contributing to the disease.

Duska J. Sidjanin, PhD, an associate professor of cell biology, neurobiology and anatomy and senior author of the study said, “These findings have implications not only for families affected with Warburg Micro syndrome, but also provide novel information about the genes and molecular pathways essential for human development that is relevant for more common developmental disorders such as epilepsy and autism.” The study was published on November 14, 2013, in the American Journal of Human Genetics.

Related Links:

Medical College of Wisconsin
University of Edinburgh 
Roche Applied Science



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Manual Pipetting Aid
Pipette Controllers macro
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.